Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
---|---|---|---|---|---|---|---|---|---|---|
|
0.090 | GeneticVariation | BEFREE | However, we did not find any association of polymorphism of XRCC1 Arg399Gln (OR = 1.56; 95% CI: 0.32-7.82) and XPD Lys751Gln (OR = 0.46; CI: 0.10-2.19) with GC risk in the study population. | 30225185 | 2018 |
||||
|
0.090 | GeneticVariation | BEFREE | However, we found no association between ERCC1 rs11615, ERCC2 rs13181, and ERCC2 rs1799793 and overall survival of gastric cancer. | 27173253 | 2016 |
||||
|
0.090 | GeneticVariation | BEFREE | We conducted a prospective study to analyze whether ERCC1 rs11615 and rs3212986 and ERCC2 rs13181 and rs1799793 gene polymorphisms could serve as potential biomarkers for the prognosis of gastric cancer. | 26823845 | 2015 |
||||
|
0.090 | GeneticVariation | BEFREE | We investigated three genotypes of XPD, at promoter -114 (rs3810366), and codon 312 (rs1799793), 751 (rs13181), and their associated with gastric cancer susceptibility in a Taiwanese population. | 26254397 | 2015 |
||||
|
0.090 | GeneticVariation | BEFREE | In conclusion, our finding suggests that ERCC1 rs3212986 and ERCC2 rs13181 gene polymorphism could influence the response to chemotherapy and clinical outcome of gastric cancer. | 26191265 | 2015 |
||||
|
0.090 | GeneticVariation | BEFREE | This meta-analysis aimed to obtain a comprehensive and reliable assessment of the relationships between XRCC1 Arg399Gln and XPD Lys751Gln polymorphisms and the clinical outcomes of gastric cancer (GC) patients treated with oxaliplatin-based chemotherapy. | 24590266 | 2014 |
||||
|
0.090 | GeneticVariation | BEFREE | We conclude that ERCC2 rs13181 polymorphism could play different roles in the overall survival of gastric cancer. | 23680703 | 2013 |
||||
|
0.090 | GeneticVariation | BEFREE | A statistically significant finding could be seen in noncardia-type gastric cancer for XPD Lys751Gln polymorphism. | 23028453 | 2012 |
||||
|
0.090 | GeneticVariation | BEFREE | This meta-analysis concluded that both ERCC2 Lys751Gln and Asp312Asn polymorphisms might contribute to increased risk of GC among Asians. | 20981556 | 2011 |